DSSTox_CID_2934

Synopsis

Synopsis

APIs // Active Pharmaceutical Ingredients

15 Suppliers, 11 USDMF, 7 CEP/COS, 6 JDMF, 4 EU WC, 5 Listed Suppliers

DOSSIERs // Finished Dosage Forms

96 Dossiers, 31 FDA Orange Book, 25 Europe, 13 Canada, 5 Australia, 10 South Africa, 12 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 0.0625MG, TABLET;ORAL - 0.125MG, TABLET;ORAL - 0.1875MG, TABLET;ORAL - 0.25MG, ELIXIR;ORAL - 0.05MG/ML, INJECTABLE;INJECTION - 0.1MG/ML, INJECTABLE;INJECTION - 0.25MG/ML

RELATED EXCIPIENT SUPPLIERS

Suppliers, 28 Kerry, 27 Roquette, 16 Gangwal Chemicals, 14 Microlex e.U, 10 Sigachi Industries, 10 SPI Pharma, 8 Vasa Pharmachem, 6 DFE Pharma, 6 BASF, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Rochem International Inc, 2 Shijiazhuang Huaxu Pharmaceutical, 1 Pfanstiehl, Inc, 1 Zhejiang Huakang Pharmaceutical, 1 Finar, 1 Ideal Cures Pvt Ltd, 1 Seppic, 1 Capsugel

EXCIPIENTS BY APPLICATIONS

76 Fillers, Diluents & Binders, 36 Direct Compression, 22 Disintegrants & Superdisintegrants, 20 Granulation, 14 Lubricants & Glidants, 12 Chewable & Orodispersible Aids, 11 Thickeners and Stabilizers, 11 Taste Masking, 10 Film Formers & Plasticizers, 9 Co-Processed Excipients, 8 Coating Systems & Additives, 7 Controlled & Modified Release, 5 Parenteral, 3 Topical, 2 API Stability Enhancers, 1 Solubilizers, 1 Soft Gelatin, 1 Rheology Modifiers, 1 Emulsifying Agents

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 19 Finished Drug Prices

MARKET PLACE

6 APIs, 3 DOSSIERS

PATENTS

1 US Exclusivities

1 US Exclusivities

ANALYTICAL SOLUTION(s)

3 EDQM Standards, 1 USP Standards, 4 JP Standards, 6 Other Ref. Standards

Find

Latest U.S. Prescription Data for Drugs containing DSSTox_CID_2934 under Medicare's Part D Prescription Drug Program. Original Data: Centers for Medicare & Medicaid Services Website

DSSTox_CID_2934

Synopsis

APIs // Active Pharmaceutical Ingredients

15 Suppliers

11 USDMF

7 CEP/COS

6 JDMF

4 EU WC

5 Listed Suppliers

DOSSIERs // Finished Dosage Forms

96 Dossiers

31 FDA Orange Book

25 Europe

13 Canada

5 Australia

10 South Africa

12 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 0.0625MG

TABLET;ORAL - 0.125MG

TABLET;ORAL - 0.1875MG

TABLET;ORAL - 0.25MG

ELIXIR;ORAL - 0.05MG/ML

INJECTABLE;INJECTION - 0.1MG/ML

INJECTABLE;INJECTION - 0.25MG/ML

RELATED EXCIPIENT SUPPLIERS

Suppliers

28 Kerry

27 Roquette

16 Gangwal Chemicals

14 Microlex e.U

10 Sigachi Industries

10 SPI Pharma

8 Vasa Pharmachem

6 DFE Pharma

6 BASF

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Rochem International Inc

2 Shijiazhuang Huaxu Pharmaceutical

1 Pfanstiehl, Inc

1 Zhejiang Huakang Pharmaceutical

1 Finar

1 Ideal Cures Pvt Ltd

1 Seppic

1 Capsugel

EXCIPIENTS BY APPLICATIONS

76 Fillers, Diluents & Binders

36 Direct Compression

22 Disintegrants & Superdisintegrants

20 Granulation

14 Lubricants & Glidants

12 Chewable & Orodispersible Aids

11 Thickeners and Stabilizers

11 Taste Masking

10 Film Formers & Plasticizers

9 Co-Processed Excipients

8 Coating Systems & Additives

7 Controlled & Modified Release

5 Parenteral

3 Topical

2 API Stability Enhancers

1 Solubilizers

1 Soft Gelatin

1 Rheology Modifiers

1 Emulsifying Agents

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions

19 Finished Drug Prices

MARKET PLACE

6 APIs

3 DOSSIERS

PATENTS

1 US Exclusivities

ANALYTICAL SOLUTION(s)

3 EDQM Standards

1 USP Standards

4 JP Standards